BioSpace News Archive

Deals

e-therapeutics: Fundraise of £13.5 million

e-therapeutics plc is pleased to announce a fundraise of £13.5 million before expenses by way of a subscription for new ordinary shares of 0.1p each (“Ordinary Shares”) in the Company (the “Subscription”) at a price of 20p per Ordinary Share by funds managed by M&G Investment Management Limited (“M&G”), an institutional investor and an existing shareholder of the Company.

September 30, 2022
·
5 min read
Lone Star Bio

TEXAS-DEVELOPED PATENT-FREE COVID-19 VACCINE TECHNOLOGY RECEIVES EMERGENCY USE AUTHORIZATION IN INDONESIA

PT Bio Farma , the holding company for state-owned pharmaceutical companies in Indonesia , is ready to produce 20 million doses of the IndoVac COVID-19 vaccine this year and 100 million doses by 2024.

September 30, 2022
·
4 min read
Deals

Zoetis Announces the Completion of its Acquisition of Jurox, a Leading Provider of Livestock and Companion Animal Products

Zoetis Inc today announced it has completed the acquisition of Jurox, a privately held animal health company that develops, manufactures and markets a wide range of veterinary medicines for treating livestock and companion animals.

September 30, 2022
·
4 min read
IMV Provides an Update on The VITALIZE Trial

IMV Inc. today provided an update on the open-label VITALIZE study evaluating its lead product maveropepimut-S (MVP-S) in combination with pembrolizumab and intermittent low-dose cyclophosphamide (CPA) in patients with relapses, refractory diffuse large B cell lymphoma (r/r DLBCL).

September 30, 2022
·
5 min read
Biotech Beach

Ainos Announces Positive Results from Additional Preclinical Study of Its Low-dose Oral Interferon Formulation Against New Variant Virus - Omicron

Ainos today announced the results from its antiviral efficacy study in hamsters against the Omicron variant of SARS-CoV-2 (the “Study”).

September 30, 2022
·
7 min read
Biotech Bay

Accuray Announces First CyberKnife® Systems in Africa, Providing a New Option and Hope for Potentially Life-Saving Radiation Treatments for More Cancer Patients

Accuray Incorporated (NASDAQ: ARAY) announced today the company is expanding its global footprint with the introduction of its CyberKnife ® platform in Africa.

September 30, 2022
·
7 min read
Deals

BiondVax announces financial plans to support its ongoing NanoAb pipeline development

BiondVax Pharmaceuticals Ltd. announced the filing yesterday of a Registration Statement (“Form F-1") with the US Securities and Exchange Commission (“SEC”) for a firm commitment underwritten offering of BiondVax American Depositary Shares (“ADSs”).

September 30, 2022
·
7 min read
BioMidwest

Oragenics Issues Letter to Shareholders - September 30, 2022

Oragenics, Inc., a biotech company dedicated to fighting infectious diseases including coronaviruses, issued the following letter to shareholders from its President and Chief Executive Officer, Kim Murphy.

September 30, 2022
·
10 min read
Drug Development

Intercept Pharmaceuticals Announces REVERSE Phase 3 Study of Obeticholic Acid (OCA) in Compensated Cirrhosis due to NASH Did Not Meet its Primary Endpoint

Intercept Pharmaceuticals, Inc. today announced that REVERSE, a Phase 3 study evaluating the safety and efficacy of OCA in patients with compensated cirrhosis due to nonalcoholic steatohepatitis (NASH).

September 30, 2022
·
5 min read
Business

Eyenovia Announces Planned Retirement of Lead Independent Director Ken Lee, Jr.

Eyenovia, Inc. today announced the planned retirement of lead independent director, Ken Lee, Jr., effective today, September 30, 2022.

September 30, 2022
·
4 min read